Journal of Drug Abuse Open Access

  • ISSN: 2471-853X
  • Journal h-index: 10
  • Journal CiteScore: 1.81
  • Journal Impact Factor: 1.92
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Articles published in Journal of Drug Abuse have been cited by esteemed scholars and scientists all around the world. Journal of Drug Abuse has got h-index 10, which means every article in Journal of Drug Abuse has got 10 average citations.

Following are the list of articles that have cited the articles published in Journal of Drug Abuse.

  2022 2021 2020 2019 2018 2017 2016

Total published articles

65 62 34 13 12 26 32

Research, Review articles and Editorials

9 10 8 2 4 8 2

Research communications, Review communications, Editorial communications, Case reports and Commentary

56 52 26 10 8 18 30

Conference proceedings

0 0 0 0 0 0 0

Citations received as per Google Scholar, other indexing platforms and portals

77 70 58 58 39 31 14
Journal total citations count 362
Journal impact factor 1.92
Journal 5 years impact factor 1.41
Journal cite score 1.81
Journal h-index 10
Important citations

Ezell JM, Walters S, Friedman SR, Bolinski R, Jenkins WD, Schneider J, Link B, Pho MT. Stigmatize the use, not the user? Attitudes on opioid use, drug injection, treatment, and overdose prevention in rural communities. Social Science & Medicine. 2021 Jan 1;268:113470.

Hautala D, Abadie R, Thrash C, Reyes JC, Dombrowski K. Latent risk subtypes based on injection and sexual behavior among people who inject drugs in rural Puerto Rico. The Journal of Rural Health. 2018 Jun;34(3):236-45.

Kim BJ, Harley DA. Needle and syringe programs in rural areas: Addressing the intravenous drug use epidemic. Rehabilitation Research, Policy, and Education. 2019 Apr 1;33(1):56-64.

Habecker P, Welch-Lazoritz M, Dombrowski K. Rural and urban differences in nebraskans’ access to marijuana, methamphetamine, heroin, and prescription pills. Journal of Drug Issues. 2018 Oct;48(4):608-24.

Clary E, Ribar C, Weigensberg E. Challenges in providing substance use disorder treatment to child welfare clients in rural communities. US Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation. 2020 Jan.

Kolak MA, Chen YT, Joyce S, Ellis K, Defever K, McLuckie C, Friedman S, Pho MT. Rural risk environments, opioid-related overdose, and infectious diseases: A multidimensional, spatial perspective. International Journal of Drug Policy. 2020 Nov 1;85:102727.

Giano, Z., Hubach, R. D., Currin, J. M., & Wheeler, D. L. (2019). Adverse childhood experiences and MSM marijuana use. Drug and alcohol dependence, 198, 76-79.

Yang XY, Yang T. Nonmedical prescription drug use among adults in their late twenties: The importance of social bonding trajectories. Journal of Drug Issues. 2017 Oct;47(4):665

Thrash C, Welch-Lazoritz M, Gauthier G, Khan B, Abadie R, Dombrowski K, De Leon SM, Rolon Colon Y. Rural and urban injection drug use in Puerto Rico: Network implications for human immunodeficiency virus and hepatitis C virus infection. Journal of ethnicity in substance abuse. 2018 Apr 3;17(2):199-222.

Coronado-García M, Thrash CR, Welch-Lazoritz M, Gauthier R, Reyes JC, Khan B, Dombrowski K. Using network sampling and recruitment data to understand social structures related to community health in a population of people who inject drugs in rural Puerto Rico. Puerto Rico health sciences journal. 2017 Jun;36(2):77.

Welch-Lazoritz M, Habecker P, Dombrowski K, Villegas AR, Davila CA, Colón YR, De León SM. Differential access to syringe exchange and other prevention activities among people who inject drugs in rural and urban areas of Puerto Rico. International Journal of Drug Policy. 2017 May 1;43:16-22.

Wagner, J., Neitzke-Spruill, L., O’Connell, D., Highberger, J., Martin, S. S., Walker, R., & Anderson, T. L. (2019). Understanding geographic and neighborhood variations in overdose death rates. Journal of community health, 44(2), 272-283.

Meyerson, B. E., Davis, A., Agley, J. D., Shannon, D. J., Lawrence, C. A., Ryder, P. T., ... & Gassman, R. (2018). Predicting pharmacy syringe sales to people who inject drugs: Policy, practice and perceptions. International Journal of Drug Policy, 56, 46-53.

Calcaterra, S. L., Bach, P., Chadi, A., Chadi, N., Kimmel, S. D., Morford, K. L., ... & Samet, J. H. (2019). Methadone matters: what the United States can learn from the global effort to treat opioid addiction. Journal of general internal medicine, 34(6), 1039-1042.

Jenkins, W. D., Bolinski, R., Bresett, J., Van Ham, B., Fletcher, S., Walters, S., ... & Ouellet, L. (2020). COVID-19 During the Opioid Epidemic-Exacerbation of Stigma and Vulnerabilities. The Journal of Rural Health: Official Journal of the American Rural Health Association and the National Rural Health Care Association.

Mack, K. A., Jones, C. M., & Ballesteros, M. F. (2017). Illicit drug use, illicit drug use disorders, and drug overdose deaths in metropolitan and nonmetropolitan areas—United States. American journal of transplantation, 17(12), 3241-3252.

Mestrinho LA, Santos RR. Translational oncotargets for immunotherapy: from pet dogs to humans. Advanced Drug Delivery Reviews. 2021 Mar 9.

Sood AK, Nemeth M, Wang J, Wu Y, Gandhi S. Opportunities for antigen discovery in metastatic breast cancer. Frontiers in Immunology. 2020 Oct 30;11:2788.

Rivero-Hinojosa S, Grant M, Panigrahi A, Zhang H, Caisova V, Bollard CM, Rood BR. Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors. Nature Communications. 2021 Nov 18;12(1):1-5.

Dong C, Cesarano A, Bombaci G, Reiter JL, Yu CY, Wang Y, Jiang Z, Zaid MA, Huang K, Lu X, Walker BA. Intron retention-induced neoantigen load correlates with unfavorable prognosis in multiple myeloma. Oncogene. 2021 Oct;40(42):6130-8.